You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 2
  • AB0372 Effect of Certolizumab Pegol on Workplace and Household Productivity in US Patients with Rheumatoid Arthritis with or without Prior Anti-Tumor Necrosis Factor Exposure: Results from the PREDICT Study

Article metrics

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Abstracts accepted for publication. Rheumatoid arthritis - anti-TNF therapy
AB0372 Effect of Certolizumab Pegol on Workplace and Household Productivity in US Patients with Rheumatoid Arthritis with or without Prior Anti-Tumor Necrosis Factor Exposure: Results from the PREDICT Study

 

Online download statistics by month:

Online download statistics by month: June 2014 to February 2024

AbstractFullPdf
Jun 2014900
Jul 2014700
Aug 20141901
Sep 20141701
Oct 20141201
Nov 2014801
Dec 2014601
Jan 2015600
Feb 2015800
Mar 20151302
Apr 2015601
May 2015300
Jun 2015400
Jul 2015200
Aug 2015300
Sep 2015800
Oct 2015601
Nov 2015602
Dec 2015400
Jan 2016500
Feb 2016600
Mar 2016701
Apr 20161000
May 2016500
Jun 2016700
Jul 2016800
Aug 2016700
Sep 2016501
Oct 2016500
Nov 2016703
Dec 2016500
Jan 20171000
Feb 2017402
Mar 20171307
Apr 2017900
May 2017501
Jun 2017502
Jul 2017802
Aug 20171000
Sep 2017600
Oct 2017601
Nov 20171203
Dec 20171000
Jan 2018801
Feb 2018600
Mar 20181000
Apr 20181400
May 20182801
Jun 20181000
Jul 2018400
Aug 20181000
Sep 2018801
Oct 2018400
Nov 20181400
Jan 2019400
Feb 2019200
Mar 2019600
Apr 2019200
Jun 2019200
Jul 2019201
Aug 2019201
Oct 20191000
Nov 2019200
Dec 2019400
Jan 2020200
Jun 2020400
Jul 2020200
Aug 2020200
Sep 2020800
Oct 2020400
Nov 2020400
Dec 2020400
Jan 2021200
Feb 2021200
Mar 2021400
Oct 2021200
Nov 2021403
Dec 2021700
Jan 2022200
Feb 2022200
Mar 2022400
Apr 2022400
May 2022600
Jul 20221000
Aug 2022600
Sep 2022200
Oct 2022200
Nov 2022600
Dec 2022800
Jan 2023900
Feb 2023200
Mar 2023200
Apr 2023600
May 2023800
Jun 2023200
Jul 2023200
Aug 2023200
Sep 2023400
Oct 2023200
Dec 2023800
Jan 2024400
Feb 2024400
Total632042